Latency-associated viral interleukin-10 (IL-10) encoded by human cytomegalovirus modulates cellular IL-10 and CCL8 Secretion during latent infection through changes in the cellular microRNA hsa-miR-92a.
cam.issuedOnline | 2014-09-24 | |
dc.contributor.author | Poole, Emma | |
dc.contributor.author | Avdic, Selmir | |
dc.contributor.author | Hodkinson, Jemima | |
dc.contributor.author | Jackson, Sarah | |
dc.contributor.author | Wills, Mark | |
dc.contributor.author | Slobedman, Barry | |
dc.contributor.author | Sinclair, John | |
dc.contributor.orcid | Poole, Emma [0000-0003-3904-6121] | |
dc.contributor.orcid | Jackson, Sarah [0000-0002-4230-9220] | |
dc.contributor.orcid | Wills, Mark [0000-0001-8548-5729] | |
dc.contributor.orcid | Sinclair, John [0000-0002-2616-9571] | |
dc.date.accessioned | 2015-12-10T17:21:37Z | |
dc.date.available | 2015-12-10T17:21:37Z | |
dc.date.issued | 2014-12 | |
dc.description.abstract | UNLABELLED: The UL111A gene of human cytomegalovirus encodes a viral homologue of the cellular immunomodulatory cytokine interleukin 10 (cIL-10), which, due to alternative splicing, results in expression of two isoforms designated LAcmvIL-10 (expressed during both lytic and latent infection) and cmvIL-10 (identified only during lytic infection). We have analyzed the functions of LAcmvIL-10 during latent infection of primary myeloid progenitor cells and found that LAcmvIL-10 is responsible, at least in part, for the known increase in secretion of cellular IL-10 and CCL8 in the secretomes of latently infected cells. This latency-associated increase in CCL8 expression results from a concomitant LAcmvIL-10-mediated suppression of the expression of the cellular microRNA (miRNA) hsa-miR-92a, which targets CCL8 directly. Taking the data together, we show that the previously observed downregulation of hsa-miR-92a and upregulation of CCL8 during HCMV latent infection of myeloid cells are intimately linked via the latency-associated expression of LAcmvIL-10. IMPORTANCE: HCMV latency causes significant morbidity and mortality in immunocompromised individuals, yet HCMV is carried silently (latently) in 50 to 90% of the population. Understanding how HCMV maintains infection for the lifetime of an infected individual is critical for the treatment of immunocompromised individuals suffering with disease as a result of HCMV. In this study, we analyze one of the proteins that are expressed during the "latent" phase of HCMV, LAcmvIL-10, and find that the expression of the gene modulates the microenvironment of the infected cell, leading to evasion of the immune system. | |
dc.description.sponsorship | This work was funded by a British Medical Research Council 5-year program grant (G0701279). | |
dc.description.version | This is the final version of the article. It first appeared from the American Society for Microbiology via http://dx.doi.org/10.1128/JVI.02424-14 | |
dc.identifier.citation | Poole et al. Journal of Virology (2014) Vol. 88, 24, pp. 13947-55. doi: 10.1128/JVI.02424-14 | |
dc.identifier.eissn | 1098-5514 | |
dc.identifier.issn | 0022-538X | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/252954 | |
dc.language | English | |
dc.language.iso | en | |
dc.publisher | American Society for Microbiology | |
dc.publisher.url | http://dx.doi.org/10.1128/jvi.02424-14 | |
dc.rights | Attribution 2.0 UK: England & Wales | |
dc.rights.uri | http://creativecommons.org/licenses/by/2.0/uk/ | |
dc.rioxxterms.funder | MRC | |
dc.rioxxterms.projectid | G0701279 | |
dc.subject | Cells, Cultured | |
dc.subject | Chemokine CCL8 | |
dc.subject | Cytomegalovirus | |
dc.subject | Humans | |
dc.subject | Interleukin-10 | |
dc.subject | MicroRNAs | |
dc.subject | Myeloid Progenitor Cells | |
dc.subject | Viral Proteins | |
dc.subject | Virus Latency | |
dc.title | Latency-associated viral interleukin-10 (IL-10) encoded by human cytomegalovirus modulates cellular IL-10 and CCL8 Secretion during latent infection through changes in the cellular microRNA hsa-miR-92a. | |
dc.type | Article | |
prism.endingPage | 13955 | |
prism.publicationDate | 2014 | |
prism.publicationName | J Virol | |
prism.startingPage | 13947 | |
prism.volume | 88 | |
pubs.funder-project-id | Medical Research Council (MR/K021087/1) | |
pubs.funder-project-id | Medical Research Council (G0701279) | |
rioxxterms.licenseref.startdate | 2014-09-24 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.type | Journal Article/Review | |
rioxxterms.versionofrecord | 10.1128/JVI.02424-14 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Poole et al 2014 Journal of Virology.pdf
- Size:
- 766.04 KB
- Format:
- Adobe Portable Document Format
- Licence
- http://creativecommons.org/licenses/by/2.0/uk/
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 3.8 KB
- Format:
- Item-specific license agreed upon to submission